...
首页> 外文期刊>Cancer causes and control: CCC >Comparability of serum, plasma, and urinary estrogen and estrogen metabolite measurements by sex and menopausal status
【24h】

Comparability of serum, plasma, and urinary estrogen and estrogen metabolite measurements by sex and menopausal status

机译:血清,血浆和尿雌激素和雌激素代谢物测量的可比性与性别和绝经地位

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PurposeThe comparability between serum, plasma, and urinary measurements of estrogen metabolites via liquid chromatography-tandem mass spectrometry (LC-MS/MS) has not been largely explored, and it is unclear if urinary LC-MS/MS measurements are suitable surrogates of circulating levels.MethodsSerum, plasma (EDTA and heparin), and urinary estrogen/estrogen metabolite levels were measured via LC-MS/MS in paired samples from 64 healthy volunteers (18 men, 20 premenopausal women, 26 postmenopausal women). Geometric means and Spearman correlation coefficients were used to compare individual and combined pathway levels of estrogens/estrogen metabolites across biologic matrices by sex/menopausal status.ResultsMeasured concentrations of estrogens/estrogen metabolites across blood matrices were almost identical (percent differences4.8%). Parent estrogen concentrations measured in serum and urine were moderately correlated in postmenopausal women (estrone: r=0.69, estradiol: r=0.69). Correlations were similar comparing unconjugated serum estradiol to urinary estrone (r=0.76) and urinary estradiol (r=0.65) in postmenopausal women but were moderate to low in premenopausal women (r=0.60, 0.40, respectively)/men (r=0.33, 0.53, respectively). Comparing metabolite ratios, proportionally higher concentrations of 16-pathway metabolites were measured in urine versus serum across sex/menopausal status groups (e.g., postmenopausal women: 50.3% 16-pathway metabolites/total in urine versus 35.3% in serum).ConclusionsThere is strong agreement between estrogen/estrogen metabolites measurements in serum, heparin plasma, and EDTA plasma. Individual estrogen metabolite concentrations were moderately correlated between urine and serum, but were not well correlated when evaluating pathway- or relative estrogen concentrations. Differences between serum and urine are likely explained by differences in metabolism and/or excretion.
机译:通过液相色谱 - 串联质谱法(LC-MS / MS)血清,血浆和尿换器尿液测量与雌激素代谢物的尿液测量的标题的可比性,并且目前尚不清楚尿液LC-MS / MS测量是否是循环的合适替代品在64个健康志愿者的配对样品中,通过LC-MS / MS测量血浆(EDTA和肝素),血浆(EDTA和肝素)和尿雌激素/雌激素代谢物水平(18名男性,20名绝经后妇女)。几何装置和Spearman相关系数用于将雌激素/雌激素代谢物的个体和组合途径水平通过性别/更年期状态进行生物学基质。血液基质上的雌激素/雌激素代谢物的雌激素浓度几乎相同(差异差异,差异为4.8%)。在绝经后妇女(Estrone:R = 0.69,雌二醇:R = 0.69)中,在血清和尿液中测量的母雌激素浓度适度相关。与绝经后妇女的未缀有的血清雌二醇与尿[0.76 r = 0.65]中的无缀合的血清雌二醇(R = 0.65)相似,但在前一女性中的中等至低于低(r = 0.60,0.40)/男性(r = 0.33, 0.53分别)。比较代谢菌素比例,在尿液与血清中测量比例较高的16-途径代谢物(例如,绝经后妇女:50.3%16-途径代谢物/尿液中的35.3%)。结论是强大的血清,肝素血浆和EDTA等离子体中雌激素/雌激素代谢物测量的同意。尿液和血清之间的单独雌激素代谢物浓度适度地相关,但在评估途径或相对雌激素浓度时不良好地相关。血清和尿液之间的差异可能通过代谢和/或排泄的差异来解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号